Dow Up 1.30% Nasdaq Up 0.37%

MannKind Corp. (MNKD)

-NasdaqGM
6.08 0.01(0.16%) Oct 30, 4:00PM EDT
Prev Close:6.07
Open:6.04
Bid:5.10 x 500
Ask:6.50 x 2000
1y Target Est:9.97
Beta:1.77
Next Earnings Date: 3-Nov-14MNKD Earnings announcement
Day's Range:5.95 - 6.15
52wk Range:3.80 - 11.48
Volume:5,682,467
Avg Vol (3m):7,704,510
Market Cap:2.34B
P/E (ttm):N/A
EPS (ttm):-0.66
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
MNKDUp 0.16%2.34B
LLY71.77B
GSK108.52B
NVO121.48B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.31
Quarterly EPS Est (Sep-14) :0.04
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):0.08

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback